Molecular Genetics of Autism
Published Online: 15 MAR 2009
Copyright © 2001 John Wiley & Sons, Ltd. All rights reserved.
How to Cite
Lamb, J. A. 2009. Molecular Genetics of Autism. eLS. .
- Published Online: 15 MAR 2009
Autism is a behaviourally defined lifelong neurodevelopmental disorder, with strong evidence for a complex genetic predisposition. Extensive genetic research has been carried out over the last decade using cytogenetic, linkage and association approaches to identify the underlying risk variants, with generally equivocal results. The most exciting recent finding to emerge in autism genetics is the discovery of submicrosopic copy number variants and rare gene mutations that appear to increase the risk of autism. These findings suggest possible biological pathways involved, pointing to postsynaptic density genes and defective glutamatergic synaptogenesis. Some of these variants are also implicated in mental retardation and other neurodevelopmental and psychiatric disorders. Together, these findings suggest considerable genetic and clinical heterogeneity underlies autism spectrum disorders, and that convergent approaches may be required to identify risk alleles.
Autism is a behaviourally defined lifelong neurodevelopmental disorder, with strong evidence for a complex genetic predisposition.
A large number of linkage and candidate gene association studies carried out over the last decade to identify risk variants have yielded generally equivocal results.
Submicrosopic copy number variants and rare gene mutations have recently been discovered that appear to increase the risk of autism; the same variants may also influence mental retardation and other neurodevelopmental and psychiatric disorders.
These findings implicate postsynaptic density genes and defective glutamatergic synaptogenesis in susceptibility to autism.
There is increasing recognition that considerable genetic and clinical heterogeneity is likely to underlie autism spectrum disorders.
Interdisciplinary, convergent approaches and large sample sizes may be required to identify the risk variants and biological pathways involved.
Technologies are rapidly evolving together with knowledge of the human genome, providing greater ability to assay genetic variation.
- copy number variation;